antigenics
Posted on April 8, 2008, 3:03 pmby admin
best video: antigenics
this a video that compose of pictures of the members of the group and some of our pics together we will upload more next time...16 antigenics
More video:
kazuma atvs
penis castration
missouri synod lutheran
leida
rio tours
burt lancaster biography
phillipines national dish recipes
corporate identity signs sunset valley
universoulcircus.com
falcon clip art
craniofacial duplication
palm springs new home
heating oil quantity
mj morning show myspace
mjmorningshow.com
On The Wires antigenics AGEN announces that the Russian Ministry of Public Health has issued a registration certificate for the use of Oncophage in the ...
http://news.moneycentral.msn.com/provider/providerarticle.aspx?feed=BCOM&date=20080408&id=8450156
NEW YORK----Antigenics Inc. today announced that it has entered into agreements to receive 26.1 million from certain investors in a private placement, subject to customary closing conditions.From: biz.yahoo.com
http://cancer-vaccine.blogspot.com/2008/01/antigenics-to-raise-26-million-in.html
NEW YORK Dow Jones--U.S. stocks futures pointed to a lower opening for equities after Alcoa and Advanced Micro Devices ticked off fears that an economic slowdown would significantly dampen the flood of earnings reports due out in the coming weeks.
http://news.ino.com/headlines/?newsid=20080408006470
Lee Biosolutions www.leebio.com Demand for high quality human semen proteins such as Human Prostate Specific Antigen and Human Acid Phosphatase PAP has increased significantly due to increase cancer research. As a result we have had collect over 10 liters of Human Semen every year to meet this demand from qualified donors.
http://www.seenation.com/view_full_news_details.php?newsid=69792" rel="dc:source" property="dc:title
Antigenics Cancer Drug Gets Russia OK. - NEW YORK AP -- Shares of antigenics Inc. spiked in Tuesday premarket trading, after the biotechnology company ...
http://biz.yahoo.com/ap/080408/antigenics_drug_approval.html?.v=1
Focusing on low toxicity treatments for a range of cancers, infections, and autoimmune and degenerative diseases.
http://www.antigenics.com/
Biotechnology company antigenics Inc. said Wednesday it agreed to sell up to 20.3 million in common shares to private investment firm ...
http://www.boston.com/business/technology/biotechnology/articles/2007/09/05/antigenics_to_sell_stock_to_investor/?rss_id=Boston+Globe+--+Technology+stories
By Anna Boyd New York-based biotechnology company antigenics Inc. announced Tuesday that it has won approval to market its cancer vaccine, Oncophage, ...Antigenics Kidney Cancer Vaccine Approved In Russia dBTechno
http://www.efluxmedia.com/news_Antigenics_Kidney_Cancer_Drug_Oncophage_Gets_Clearance_in_Russia_16110.html
The Phase 3, international, multicenter, open-label misery protocol C-100-21 randomized 322 patients with exhibit IV melanoma at 71 centers in the United States, Russia/Ukraine, Europe and Australia. Patients were randomized to one of two healing arms: Oncophage or physician's choice, in a 2:1 relationship favoring Oncophage, and prospectively stratified based on AJCC metastatic originate M1a, M1b, M1c and ECOG significance at baseline. Physician's exquisite included interleukin 2 IL-2 a
http://1-online-drug-store.com/blog/hospital-trials/antigenics-announces-publication-of-phase-3-melanoma-study-results-in-journal-of-clinical-oncology-hospital-trials/
The tiny biotechnology company antigenics Inc said on Tuesday it has won approval to market its kidney cancer vaccine, Oncophage, in Russia, making it the only cancer vaccine available in the world.
http://news.yahoo.com/s/nm/20080408/hl_nm/antigenics_dc_1
Lee Biosolutionswww.leebio.com has available the highest purity polyclonal c-reactive protein. The affinity purified Polyclonal antibody anti-Human c-reactive protein. C Reactive Protein reacts only with C-Reactive Protein CRP by ELISA, IEP and Double Diffusion. Human C-reactive protein, Canine C-reactive protein, rat c-reactive protein antigen.
http://www.linscottsdirectory.com/dir/2.2.1/module/Dir/action/ViewDetails/key/QW50aWJvZHk6MzI1MTA1Njk%3D" rel="dc:source" property="dc:title
Antigenics&39 Oncophage is a revolutionary patient-specific vaccine designed to treat cancer with minimal side effects.
http://www.antigenics.com/products/cancer/oncophage/
Antigenics' Oncophage is a revolutionary patient-specific vaccine designed to treat cancer with ... antigenics also plans to investigate Oncophage in clinical ...
http://www.antigenics.com/products/cancer/oncophage/
Antigenics' business is subject to substantial risks and uncertainties, including those identified above.
http://biz.yahoo.com/bw/080321/20080321005027.html?.v=1
AntiGenics NASDAQ:AGEN is up 30% on news that one of its drugs was approved for use in Russia. Fannie Mae NYSE:FNM is up almost 3% on a brokerage ...
http://www.bloggingstocks.com/2008/04/08/pre-market-movers-amd-fnm/
antigenics Inc. NASDAQ: AGEN announced the publication of results from a Phase 3 study of Oncophage vitespen cancer vaccine as an investigational treatment for metastatic melanoma in the February 20, 2008 issue of the Journal of Clinical Oncology. The published data showed that patients receiving at least 10 injections of Oncophage had improved median survival compared with physician??s choice.Original post by Allergy News From Medical News Today
http://rxjournals.com/?p=10542
Source: Reuters By Toni Clarke BOSTON, April 8 Reuters - The tiny biotechnology company antigenics Inc said on Tuesday it has won approval to market its kidney cancer vaccine, Oncophage, in Russia ...
http://www.alertnet.org/thenews/newsdesk/N07281163.htm
PSA doubling time of less than 15 months after prostatectomy may reliably select patients for novel clinical trial strategies since their prostate cancer related death approaches 90 percent
http://www.medicalnewstoday.com/articles/73772.php" rel="dc:source" property="dc:title
Antigenics Reports Fourth Quarter and Year-End 2007 Financial Results ... The Maybach Review: Has added antigenics Inc. to their watch list ...
http://boston.stockgroup.com/sn_overview.asp?symbol=AGEN
News on antigenics continually updated from thousands of sources around the net. ... antigenics Announces Publication of Phase 3 Melanoma Study Results in Journal of ...
http://www.topix.net/com/agen
Biotechnology company developing cancer vaccines and other treatments for cancer and infectious diseases...
http://www.antigenics.com/
"The registration of Oncophage in Russia represents an important treatment advancement for patients with intermediate-risk kidney cancer," antigenics Inc ...
http://en.rian.ru/world/20080408/104070854.html
antigenics Inc. NASDAQ: AGEN A study for Cancer vaccine, Oncophage, for the treatment of metastatic melanoma showed mixed results this morning. Shares are down almost 7% to 2.17. The 52 week range is 1.54 to 5.42. Cell Genesys, Inc. NASDAQ: CEGE. Shares continue to climb following report Friday citing that vaccine candidate GCAX showed immune response in prostate cancer patients. Shares are trading at 2.93 in mid-day trading. The 52 week range is 1.78 to 7.30. IDM Pharma, Inc. NAS
http://www.247wallst.com/2008/02/major-biotech-m.html
BellwetherReport.com is the leading online financial newsletter for investors seeking top independent and unbiased research. Investors seeking free and unbiased research on the companies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports. Today, we have scheduled interviews with a number of the top analysts in North ...
http://biz.yahoo.com/iw/080408/0384723.html
www.leebio.com, Lee Biosolutions is offering myoglobin antigen derived from human heart tissue, Polyclonal sheep anti-human myoglobin, and engineered recombinant myoglobin.
http://www.seenation.com/view_full_news_details.php?newsid=69935" rel="dc:source" property="dc:title
Aug 24, 2007 ... antigenics AGEN is a biotech company that specializes in cancer vaccines and other adjuvants. Recent positive activities have encouraged ...
http://seekingalpha.com/article/45535
Biotechnology company developing cancer vaccines and other treatments for cancer and infectious diseases
http://www.antigenics.com/
http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ANTIGENICS+INC+DE+++++++For%3A+Mar+21/3479503.html
4/8/2008 6:36:55 AM antigenics Inc. AGEN announced that the Russian Ministry of Public Health has issued a registration certificate for the use of ...
http://www.rttnews.com/sp/Quickfactsnew.asp?date=04/08/2008&item=44
It??s Leap Day, so why not take a leap? Major Corporation - Litigation Attorney - Strategic Legal Solutions, Rye, NY Sr. Attorney - Walgreen Company, Deerfield, IL Counsel - AIG SunAmerica , Century City, CA Senior Attorney - Antigenics, Inc., Lexington, MA Boston Area Attorney - Microsoft Corporation, Redmond, WA In-House Counsel - Confidential, New York, NY Commercial Attorney - Publicly Traded Biotechnology Company, Northern New Jersey Senior Regulatory Counsel - Publicly Traded Pharmaceu
http://www.inhouseblog.com/feeder/?FeederAction=clicked&feed=Articles+%28Atom%29&seed=http%3A%2F%2Fwww.inhouseblog.com%2F2008%2F02%2Fleap_into_an_in-house_counsel_job.html&seed_title=Leap+Into+an+In-House+Counsel+Job
MOSCOW, April 8 RIA Novosti - A U.S. biotechnology company said on Tuesday that Russia's Health Ministry has given approval to register a breakthrough treatment for kidney cancer, which will prevent the reoccurrence of the disease.
http://en.rian.ru/world/20080408/104070854.html
Prostate specific antigen PSA levels typically have correlated with prostate biopsy results in the detection of prostate cancer,
http://www.treasurelifemag.com/index.php/biopsy-techniques-have-made-psa-test-less-predictive/" rel="dc:source" property="dc:title
Antigenics Inc. NASDAQ: AGEN announced the publication of results from a Phase 3 study of Oncophage vitespen cancer vaccine as an investigational ...
http://www.medicalnewstoday.com/articles/98209.php
Biotechnology company developing cancer vaccines and other treatments for cancer and infectious diseases
http://HSPVACCINES.COM
Antigenics investors information ... March 21 antigenics to Present Phase 3 Oncophage vitespen Data in Kidney Cancer at European ...
http://www.antigenics.com/investors/
Antigenics Inc. NASDAQ: AGEN 30% HIGHER announced that the Russian Ministry of Public Health has issued a registration certificate for the use of ...
http://www.streetinsider.com/Special+Reports/Pre-Open+Movers+48:+First+Marblehead+FMD+Sinks+As+Client+Files+Bankruptcy,+NutriSystem+NTRI+Higher+on+Mngmt+ChangeGuidance/3528134.html
Antigenics Inc. AGEN Close to Commercial Business Start February 26th, 2008 The most important management announcement during declaration of business results for the Most Recent Quarter is that the company is set to make a commercial launch in the anti-cancer segment of the Russian market during the second half of 2008. The company has made impressive business progress during the last four quarters and during the Most Recent Quarter as well. Annual losses have been slashed from about 52 m
http://Blog.QualityStocks.net/?p=8077
BOSTON, April 8 - Tiny biotechnology company antigenics Inc said on Tuesday it has won approval to market its kidney cancer vaccine Oncophage in Russia, making it the only cancer vaccine available in the world, pushing its shares up more than 50 percent in early trading.
http://sg.news.yahoo.com/rtrs/20080408/tbs-antigenics-7318940.html
Prostate specific antigen PSA levels typically have correlated with prostate biopsy results in the detection of prostate cancer, but that correlation no longer exists for men with a normal prostate exam, according to a new study.
http://www.sciencedaily.com/releases/2008/03/080310092351.htm" rel="dc:source" property="dc:title
This morning a little biotech company, Antigenics, announced that Russia has approved its kidney cancer drug Oncophage. It&39s the first so-called therapeutic ...
http://www.cnbc.com/id/24010964?__source=RSS*blog*&par=RSS
See stock analyst recommendations for antigenics INC AGEN, including history of rankings upgrades, downgrades ... Data provided by Briefing.com - Take a ...
http://finance.yahoo.com/q/ao?s=agen
... be a major setback for Antigenics. Monane, whose firm has done investment banking for Antigenics, said he continues to expect Oncophage ...
http://www.marketwatch.com/news/story/antigenics-shares-slide-after-oncophage/story.aspx?guid=%7BF3BB1C49%2DC5A0%2D4F4E%2DA6F9%2D43AF14676CF5%7D
this a video that compose of pictures of the members of the group and some of our pics together we will upload more next time...16 antigenics
More video:
 |  |
kazuma atvs
penis castration
missouri synod lutheran
leida
rio tours
burt lancaster biography
phillipines national dish recipes
corporate identity signs sunset valley
universoulcircus.com
falcon clip art
craniofacial duplication
palm springs new home
heating oil quantity
mj morning show myspace
mjmorningshow.com
Market Report -- In Play WIRES - MSN Money
On The Wires antigenics AGEN announces that the Russian Ministry of Public Health has issued a registration certificate for the use of Oncophage in the ...
http://news.moneycentral.msn.com/provider/providerarticle.aspx?feed=BCOM&date=20080408&id=8450156
Antigenics to Raise 26 Million in Private Placement
NEW YORK----Antigenics Inc. today announced that it has entered into agreements to receive 26.1 million from certain investors in a private placement, subject to customary closing conditions.From: biz.yahoo.com
http://cancer-vaccine.blogspot.com/2008/01/antigenics-to-raise-26-million-in.html
BEFORE THE BELL: US Stk Futures Down On Alcoa, Advanced Micro INO News
NEW YORK Dow Jones--U.S. stocks futures pointed to a lower opening for equities after Alcoa and Advanced Micro Devices ticked off fears that an economic slowdown would significantly dampen the flood of earnings reports due out in the coming weeks.
http://news.ino.com/headlines/?newsid=20080408006470
Prostate Specific Antigen -Prostate Cancer
Lee Biosolutions www.leebio.com Demand for high quality human semen proteins such as Human Prostate Specific Antigen and Human Acid Phosphatase PAP has increased significantly due to increase cancer research. As a result we have had collect over 10 liters of Human Semen every year to meet this demand from qualified donors.
http://www.seenation.com/view_full_news_details.php?newsid=69792" rel="dc:source" property="dc:title
Antigenics Cancer Drug Gets Russia OK: Financial News - Yahoo! Finance
Antigenics Cancer Drug Gets Russia OK. - NEW YORK AP -- Shares of antigenics Inc. spiked in Tuesday premarket trading, after the biotechnology company ...
http://biz.yahoo.com/ap/080408/antigenics_drug_approval.html?.v=1
ANTIGENICS - Personalized cancer vaccines and other revolutionary treatments
Focusing on low toxicity treatments for a range of cancers, infections, and autoimmune and degenerative diseases.
http://www.antigenics.com/
Antigenics to sell stock to investor - Boston.com
Biotechnology company antigenics Inc. said Wednesday it agreed to sell up to 20.3 million in common shares to private investment firm ...
http://www.boston.com/business/technology/biotechnology/articles/2007/09/05/antigenics_to_sell_stock_to_investor/?rss_id=Boston+Globe+--+Technology+stories
Antigenics?? Kidney Cancer Drug Oncophage Gets Clearance in Russia - eFluxMedia
By Anna Boyd New York-based biotechnology company antigenics Inc. announced Tuesday that it has won approval to market its cancer vaccine, Oncophage, ...Antigenics Kidney Cancer Vaccine Approved In Russia dBTechno
http://www.efluxmedia.com/news_Antigenics_Kidney_Cancer_Drug_Oncophage_Gets_Clearance_in_Russia_16110.html
Antigenics Announces Publication of Phase 3 Melanoma Study Results in Journal of Clinical Oncology. Hospital trials.
The Phase 3, international, multicenter, open-label misery protocol C-100-21 randomized 322 patients with exhibit IV melanoma at 71 centers in the United States, Russia/Ukraine, Europe and Australia. Patients were randomized to one of two healing arms: Oncophage or physician's choice, in a 2:1 relationship favoring Oncophage, and prospectively stratified based on AJCC metastatic originate M1a, M1b, M1c and ECOG significance at baseline. Physician's exquisite included interleukin 2 IL-2 a
http://1-online-drug-store.com/blog/hospital-trials/antigenics-announces-publication-of-phase-3-melanoma-study-results-in-journal-of-clinical-oncology-hospital-trials/
Antigenics wins Russian approval of cancer vaccine Reuters via Yahoo! News
The tiny biotechnology company antigenics Inc said on Tuesday it has won approval to market its kidney cancer vaccine, Oncophage, in Russia, making it the only cancer vaccine available in the world.
http://news.yahoo.com/s/nm/20080408/hl_nm/antigenics_dc_1
Polyclonal C-Reactive Protein, C-Reactive Protein Antigen
Lee Biosolutionswww.leebio.com has available the highest purity polyclonal c-reactive protein. The affinity purified Polyclonal antibody anti-Human c-reactive protein. C Reactive Protein reacts only with C-Reactive Protein CRP by ELISA, IEP and Double Diffusion. Human C-reactive protein, Canine C-reactive protein, rat c-reactive protein antigen.
http://www.linscottsdirectory.com/dir/2.2.1/module/Dir/action/ViewDetails/key/QW50aWJvZHk6MzI1MTA1Njk%3D" rel="dc:source" property="dc:title
Oncophage patient-specific cancer vaccine
Antigenics&39 Oncophage is a revolutionary patient-specific vaccine designed to treat cancer with minimal side effects.
http://www.antigenics.com/products/cancer/oncophage/
Oncophage patient-specific cancer vaccine
Antigenics' Oncophage is a revolutionary patient-specific vaccine designed to treat cancer with ... antigenics also plans to investigate Oncophage in clinical ...
http://www.antigenics.com/products/cancer/oncophage/
Antigenics to Present Phase 3 OncophageR vitespen Data in Kidney ...
Antigenics' business is subject to substantial risks and uncertainties, including those identified above.
http://biz.yahoo.com/bw/080321/20080321005027.html?.v=1
Pre-market movers AMD FNM - BloggingStocks
AntiGenics NASDAQ:AGEN is up 30% on news that one of its drugs was approved for use in Russia. Fannie Mae NYSE:FNM is up almost 3% on a brokerage ...
http://www.bloggingstocks.com/2008/04/08/pre-market-movers-amd-fnm/
Antigenics Announces Publication Of Phase 3 Melanoma Study Results In Journal Of Clinical Oncology
antigenics Inc. NASDAQ: AGEN announced the publication of results from a Phase 3 study of Oncophage vitespen cancer vaccine as an investigational treatment for metastatic melanoma in the February 20, 2008 issue of the Journal of Clinical Oncology. The published data showed that patients receiving at least 10 injections of Oncophage had improved median survival compared with physician??s choice.Original post by Allergy News From Medical News Today
http://rxjournals.com/?p=10542
Antigenics wins Russian approval of cancer vaccine AlertNet
Source: Reuters By Toni Clarke BOSTON, April 8 Reuters - The tiny biotechnology company antigenics Inc said on Tuesday it has won approval to market its kidney cancer vaccine, Oncophage, in Russia ...
http://www.alertnet.org/thenews/newsdesk/N07281163.htm
Prostate-Specific Antigen Doubling Time Subgroups
PSA doubling time of less than 15 months after prostatectomy may reliably select patients for novel clinical trial strategies since their prostate cancer related death approaches 90 percent
http://www.medicalnewstoday.com/articles/73772.php" rel="dc:source" property="dc:title
boston.stockgroup.com - Overview
Antigenics Reports Fourth Quarter and Year-End 2007 Financial Results ... The Maybach Review: Has added antigenics Inc. to their watch list ...
http://boston.stockgroup.com/sn_overview.asp?symbol=AGEN
Antigenics News - Topix
News on antigenics continually updated from thousands of sources around the net. ... antigenics Announces Publication of Phase 3 Melanoma Study Results in Journal of ...
http://www.topix.net/com/agen
Antigenics, Inc.
Biotechnology company developing cancer vaccines and other treatments for cancer and infectious diseases...
http://www.antigenics.com/
Antigenics wins Russian approval for breakthrough cancer therapy - RIA Novosti
"The registration of Oncophage in Russia represents an important treatment advancement for patients with intermediate-risk kidney cancer," antigenics Inc ...
http://en.rian.ru/world/20080408/104070854.html
Major Biotech Movers AGEN, CEGE, ENCY, IDMI, IMCL, ONXX, PFE, NTII, OXGN, PSDV, SIRT
antigenics Inc. NASDAQ: AGEN A study for Cancer vaccine, Oncophage, for the treatment of metastatic melanoma showed mixed results this morning. Shares are down almost 7% to 2.17. The 52 week range is 1.54 to 5.42. Cell Genesys, Inc. NASDAQ: CEGE. Shares continue to climb following report Friday citing that vaccine candidate GCAX showed immune response in prostate cancer patients. Shares are trading at 2.93 in mid-day trading. The 52 week range is 1.78 to 7.30. IDM Pharma, Inc. NAS
http://www.247wallst.com/2008/02/major-biotech-m.html
BellwetherReport.com Free Analyst Review for RGEN, AGEN, ASML and NTRI Marketwire via Yahoo! Finance
BellwetherReport.com is the leading online financial newsletter for investors seeking top independent and unbiased research. Investors seeking free and unbiased research on the companies mentioned in this release are encouraged to sign up to www.bellwetherreport.com for a free subscription to access these reports. Today, we have scheduled interviews with a number of the top analysts in North ...
http://biz.yahoo.com/iw/080408/0384723.html
Human Myoglobin, Myoglobin producer, Myoglobin Research, Myoglobin antigen
www.leebio.com, Lee Biosolutions is offering myoglobin antigen derived from human heart tissue, Polyclonal sheep anti-human myoglobin, and engineered recombinant myoglobin.
http://www.seenation.com/view_full_news_details.php?newsid=69935" rel="dc:source" property="dc:title
Is Antigenics a Good Buy Right Now? - Seeking Alpha
Aug 24, 2007 ... antigenics AGEN is a biotech company that specializes in cancer vaccines and other adjuvants. Recent positive activities have encouraged ...
http://seekingalpha.com/article/45535
ANTIGENICS - Personalized cancer vaccines and other revolutionary ...
Biotechnology company developing cancer vaccines and other treatments for cancer and infectious diseases
http://www.antigenics.com/
Form 8-K ANTIGENICS INC /DE/ For: Mar 21
http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ANTIGENICS+INC+DE+++++++For%3A+Mar+21/3479503.html
Jaco Electronics Bags Order To Make 4500 Voting Machines For New ... - RTT News
4/8/2008 6:36:55 AM antigenics Inc. AGEN announced that the Russian Ministry of Public Health has issued a registration certificate for the use of ...
http://www.rttnews.com/sp/Quickfactsnew.asp?date=04/08/2008&item=44
Leap Into an In-House Counsel Job
It??s Leap Day, so why not take a leap? Major Corporation - Litigation Attorney - Strategic Legal Solutions, Rye, NY Sr. Attorney - Walgreen Company, Deerfield, IL Counsel - AIG SunAmerica , Century City, CA Senior Attorney - Antigenics, Inc., Lexington, MA Boston Area Attorney - Microsoft Corporation, Redmond, WA In-House Counsel - Confidential, New York, NY Commercial Attorney - Publicly Traded Biotechnology Company, Northern New Jersey Senior Regulatory Counsel - Publicly Traded Pharmaceu
http://www.inhouseblog.com/feeder/?FeederAction=clicked&feed=Articles+%28Atom%29&seed=http%3A%2F%2Fwww.inhouseblog.com%2F2008%2F02%2Fleap_into_an_in-house_counsel_job.html&seed_title=Leap+Into+an+In-House+Counsel+Job
Antigenics wins Russian approval for breakthrough cancer therapy Russian Information Agency Novosti
MOSCOW, April 8 RIA Novosti - A U.S. biotechnology company said on Tuesday that Russia's Health Ministry has given approval to register a breakthrough treatment for kidney cancer, which will prevent the reoccurrence of the disease.
http://en.rian.ru/world/20080408/104070854.html
Biopsy techniques have made PSA test less predictive
Prostate specific antigen PSA levels typically have correlated with prostate biopsy results in the detection of prostate cancer,
http://www.treasurelifemag.com/index.php/biopsy-techniques-have-made-psa-test-less-predictive/" rel="dc:source" property="dc:title
Antigenics Announces Publication Of Phase 3 Melanoma Study Results ...
Antigenics Inc. NASDAQ: AGEN announced the publication of results from a Phase 3 study of Oncophage vitespen cancer vaccine as an investigational ...
http://www.medicalnewstoday.com/articles/98209.php
ANTIGENICS - Personalized cancer vaccines and other revolutionary ...
Biotechnology company developing cancer vaccines and other treatments for cancer and infectious diseases
http://HSPVACCINES.COM
Antigenics investors information
Antigenics investors information ... March 21 antigenics to Present Phase 3 Oncophage vitespen Data in Kidney Cancer at European ...
http://www.antigenics.com/investors/
Pre-Open Movers 4/8: First Marblehead FMD Sinks As Client Files ... - StreetInsider.com subscription
Antigenics Inc. NASDAQ: AGEN 30% HIGHER announced that the Russian Ministry of Public Health has issued a registration certificate for the use of ...
http://www.streetinsider.com/Special+Reports/Pre-Open+Movers+48:+First+Marblehead+FMD+Sinks+As+Client+Files+Bankruptcy,+NutriSystem+NTRI+Higher+on+Mngmt+ChangeGuidance/3528134.html
Antigenics Inc. AGEN Close to Commercial Business Start
Antigenics Inc. AGEN Close to Commercial Business Start February 26th, 2008 The most important management announcement during declaration of business results for the Most Recent Quarter is that the company is set to make a commercial launch in the anti-cancer segment of the Russian market during the second half of 2008. The company has made impressive business progress during the last four quarters and during the Most Recent Quarter as well. Annual losses have been slashed from about 52 m
http://Blog.QualityStocks.net/?p=8077
Antigenics wins Russian approval of cancer vaccine Reuters via Yahoo! Singapore News
BOSTON, April 8 - Tiny biotechnology company antigenics Inc said on Tuesday it has won approval to market its kidney cancer vaccine Oncophage in Russia, making it the only cancer vaccine available in the world, pushing its shares up more than 50 percent in early trading.
http://sg.news.yahoo.com/rtrs/20080408/tbs-antigenics-7318940.html
Prostate Cancer Screening
Prostate specific antigen PSA levels typically have correlated with prostate biopsy results in the detection of prostate cancer, but that correlation no longer exists for men with a normal prostate exam, according to a new study.
http://www.sciencedaily.com/releases/2008/03/080310092351.htm" rel="dc:source" property="dc:title
Antigenics Finds That "Russian Roulette" Pays Off - Pharmas Market ...
This morning a little biotech company, Antigenics, announced that Russia has approved its kidney cancer drug Oncophage. It&39s the first so-called therapeutic ...
http://www.cnbc.com/id/24010964?__source=RSS*blog*&par=RSS
AGEN: Analyst Opinion for ANTIGENICS INC - Yahoo! Finance
See stock analyst recommendations for antigenics INC AGEN, including history of rankings upgrades, downgrades ... Data provided by Briefing.com - Take a ...
http://finance.yahoo.com/q/ao?s=agen
Antigenics shares slide after Oncophage regulatory snag - ...
... be a major setback for Antigenics. Monane, whose firm has done investment banking for Antigenics, said he continues to expect Oncophage ...
http://www.marketwatch.com/news/story/antigenics-shares-slide-after-oncophage/story.aspx?guid=%7BF3BB1C49%2DC5A0%2D4F4E%2DA6F9%2D43AF14676CF5%7D